Word

GENOVAC NANO

Status

Registered

Status Code

700

Status Date

Tuesday, September 26, 2023

Serial Number

97457305

Registration Number

7177988

Registration Date

Tuesday, September 26, 2023

Mark Type

4000

Filing Date

Tuesday, June 14, 2022

Published for Opposition

Tuesday, March 28, 2023

Trademark Owner History

Genovac Antibody Discovery LLC - Original Registrant

Classifications

40 Biomanufacturing for others, namely, manufacturing of antibodies, proteins, and plasmids using biological organisms in the manufacturing process

42 Biotechnology research; Pharmaceutical research and development; Pharmaceutical research services; Development of new technology for others in the field of biotechnology and pharmaceuticals; Laboratory research services relating to pharmaceuticals; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the pharmaceutical and biotechnology fields; Research on the subject of pharmaceuticals; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy

"NANO"

Trademark Events

Sep 26, 2023

Notice Of Registration Confirmation Emailed

Sep 26, 2023

Registered-Principal Register

Aug 23, 2023

Notice Of Acceptance Of Statement Of Use E-Mailed

Aug 22, 2023

Allowed Principal Register - Sou Accepted

Jul 18, 2023

Statement Of Use Processing Complete

Jun 21, 2023

Use Amendment Filed

Jul 18, 2023

Case Assigned To Intent To Use Paralegal

Jun 21, 2023

Teas Statement Of Use Received

May 23, 2023

Noa E-Mailed - Sou Required From Applicant

Mar 28, 2023

Official Gazette Publication Confirmation E-Mailed

Mar 28, 2023

Published For Opposition

Mar 8, 2023

Notification Of Notice Of Publication E-Mailed

Feb 21, 2023

Approved For Pub - Principal Register

Feb 21, 2023

Examiner's Amendment Entered

Feb 21, 2023

Notification Of Examiners Amendment E-Mailed

Feb 21, 2023

Examiners Amendment E-Mailed

Feb 21, 2023

Examiners Amendment -Written

Feb 13, 2023

Assigned To Examiner

Jun 27, 2022

New Application Office Supplied Data Entered

Jun 17, 2022

New Application Entered